COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …

The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …

Many people infected with the SARS-CoV-2 suffer long-term symptoms, such as “brain fog”,
fatigue and clotting problems. Explanations for “long COVID” include immune imbalance …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV …

Of those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),~
10% develop the chronic post-viral debilitating condition, long COVID (LC). Although LC is a …

The novel coronavirus disease 19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), can have two phases: acute (generally 4 weeks …

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition
characterized by an elusive etiology and pathophysiology. This study aims to evaluate the …

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex condition
arising in susceptible people, predominantly following viral infection, but also other stressful …

Long COVID, also referred to as Post-Acute Sequelae of COVID (PASC), is probably
triggered during SARS-CoV-2 infection and acute COVID-19 by SARS-CoV-2 Spike-protein …

After five waves of coronavirus disease 2019 (COVID-19) outbreaks, it has been recognized
that a significant portion of the affected individuals developed long-term debilitating …